Acquiring Company
Ligand Pharmaceuticals Incorporated
Acquired Company
XOMA Royalty Corporation
San DiegoEmeryvilleBiotechnologyHealthcareHealth CarePharmaceuticalBiopharmaBiotechnologyHealth CareDescription
Ligand Pharmaceuticals Incorporated has agreed to acquire XOMA Corporation in a deal valued at $739 million in cash and contingent value rights (CVR). This merger marks a significant move for Ligand in expanding its portfolio in the biopharmaceutical sector. The agreement includes customary restrictions preventing XOMA from seeking alternative acquisition proposals.
Who to call at Ligand Pharmaceuticals Incorporated, and when
When Ligand Pharmaceuticals Incorporated changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Ligand Pharmaceuticals Incorporated raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ligand Pharmaceuticals Incorporated, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ligand Pharmaceuticals Incorporated makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired XOMA Royalty Corporation?
XOMA Royalty Corporation was acquired by Ligand Pharmaceuticals Incorporated, based in San Diego. The deal was reported on April 27, 2026. Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand Pharmaceuticals Incorporated is publicly traded (LGND) and operates in Biotechnology.
When did Ligand Pharmaceuticals Incorporated acquire XOMA Royalty Corporation?
Ligand Pharmaceuticals Incorporated's acquisition of XOMA Royalty Corporation was reported on April 27, 2026. Ligand Pharmaceuticals Incorporated has agreed to acquire XOMA Corporation in a deal valued at $739 million in cash and contingent value rights (CVR). This merger marks a significant move for Ligand in expanding its portfolio in the biopharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does XOMA Royalty Corporation do?
XOMA Royalty Corporation is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. It is privately held, operating in Biotechnology, and is based in Emeryville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.